Found: 15
Select item for more details and to access through your institution.
Effect of Growth Hormone Replacement on BMD in Adult-Onset Growth Hormone Deficiency.
- Published in:
- Journal of Bone & Mineral Research, 2007, v. 22, n. 5, p. 762, doi. 10.1359/JBMR.070205
- By:
- Publication type:
- Article
Examining the evidence for weight management in individuals with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1411, doi. 10.1111/dom.14764
- By:
- Publication type:
- Article
A model‐based simulation of glycaemic control and body weight when switching from semaglutide to 3.0‐ and 4.5‐mg doses of once‐weekly dulaglutide.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 302, doi. 10.1111/dom.14582
- By:
- Publication type:
- Article
Glycaemic efficacy of an expanded dose range of dulaglutide according to baseline glycated haemoglobin (HbA1c) subgroup: Post hoc analysis of AWARD‐11.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 12, p. 2819, doi. 10.1111/dom.14533
- By:
- Publication type:
- Article
Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2242, doi. 10.1111/dom.14465
- By:
- Publication type:
- Article
Glucagon-like peptide-1 receptor agonists compared with basal insulins for the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 228, doi. 10.1111/dom.12805
- By:
- Publication type:
- Article
IGF-I measurements in the diagnosis of adult growth hormone deficiency.
- Published in:
- Pituitary, 2007, v. 10, n. 2, p. 151, doi. 10.1007/s11102-007-0028-8
- By:
- Publication type:
- Article
Impact of Weight Change on Glycemic Control and Metabolic Parameters in T2D: A Retrospective US Study Based on Real-World Data.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 2, p. 409, doi. 10.1007/s13300-023-01511-4
- By:
- Publication type:
- Article
Use of Twice-Daily Exenatide in Basal Insulin--Treated Patients With Type 2 Diabetes.
- Published in:
- Annals of Internal Medicine, 2011, v. 154, n. 2, p. 103, doi. 10.7326/0003-4819-154-2-201101180-00300
- By:
- Publication type:
- Article
HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes.
- Published in:
- Diabetes Care, 2012, v. 35, n. 5, p. 955, doi. 10.2337/dc11-1434
- By:
- Publication type:
- Article
651-P: Higher Doses of Dulaglutide Induce Weight Loss in Patients with Type 2 Diabetes (T2D) Regardless of Baseline BMI: Post-hoc Analysis of AWARD-11.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-651-P
- By:
- Publication type:
- Article
643-P: A Model-Based Evaluation of Glycemic and Weight Changes When Switching from Semaglutide to Additional Doses of Dulaglutide.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-643-P
- By:
- Publication type:
- Article
929-P: Dulaglutide Shows Sustained A1C Reduction: Two-Year U.S. Real-World Study.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-929-P
- By:
- Publication type:
- Article
233-OR: Chronic Kidney Disease (CKD) Outcomes with Dulaglutide (DU) vs. Insulin Glargine (IG) in Type 2 Diabetes (T2D) and Moderate-to-Severe CKD by Albuminuria Status: AWARD-7.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-233-OR
- By:
- Publication type:
- Article